Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Choroidal neovascularization.

Hans E Grossniklaus1, W Richard Green

  • 1Departments of Ophthalmology and Pathology, Emory University School of Medicine, Atlanta, Georgia 30322, USA.

American Journal of Ophthalmology
|March 12, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ophthalmic Rosai-Dorfman Disease and the Revised Classification of Histiocytoses: A Case Series and Review of the Literature.

Ophthalmic plastic and reconstructive surgery·2026
Same author

The emerging role of metabolic interventions in uveal melanoma.

Seminars in cancer biology·2025
Same author

Long-term functional rescue of trauma-induced vision loss by a novel, small molecule TrkB modulator.

PloS one·2025
Same author

Case Series: Retinal Pigment Epithelial Detachments Over Choroidal Nevi - What Is the Clinical Significance?

Ocular oncology and pathology·2025
Same author

Magnetically steered cell therapy for reduction of intraocular pressure as a treatment strategy for open-angle glaucoma.

eLife·2025
Same author

Targeting the VIP-VPAC Pathway in Melanoma Models Inhibits Tumor Growth and Liver Metastasis.

Cancer letters·2025
Same journal

Reply to Comment on Visual Field Progression in Glaucoma Patients with Delayed Follow-Up.

American journal of ophthalmology·2026
Same journal

Comment on: "Safety and efficiency reducing retinopathy of prematurity guideline sensitivity: an external validation using a large US-based dataset".

American journal of ophthalmology·2026
Same journal

Reply to Comment on "Clinicopathological and Imaging Distinction Between Ocular Adnexal MALT Lymphoma and IgG4-Related Ophthalmic Disease".

American journal of ophthalmology·2026
Same journal

Comment on: Visual Field Progression in Glaucoma Patients With Delayed Follow-Up.

American journal of ophthalmology·2026
Same journal

Corneal sensitivity changes and nerve plexus abnormalities in noninfectious anterior uveitis.

American journal of ophthalmology·2026
Same journal

Role of Menopausal Hormone Therapy on Strabismus, Strabismus Surgery, and Reoperation Rates.

American journal of ophthalmology·2026
See all related articles

Choroidal neovascularization (CNV) is a common response to stimuli, with distinct growth patterns and stages. Understanding its pathobiology advances new treatments for this condition.

Area of Science:

  • Ophthalmology
  • Pathology
  • Medical Research

Background:

  • Choroidal neovascularization (CNV) is a significant cause of vision loss.
  • Understanding the underlying pathobiology is crucial for effective treatment strategies.

Purpose of the Study:

  • To review clinicopathologic findings of CNV.
  • To provide a historical perspective on CNV research.
  • To correlate pathobiology with current and emerging treatments.

Main Methods:

  • Selective literature review.
  • Incorporation of authors' clinical experience.

Main Results:

  • CNV is a stereotypic response to specific stimuli.
  • Common CNV growth patterns include subretinal pigment epithelium (type 1), subretinal (type 2), and combined.

Related Experiment Videos

  • CNV progresses through distinct stages: initiation, active, and involutional.
  • Modern understanding of CNV growth informs treatment development.
  • Conclusions:

    • Significant progress has been made in understanding CNV pathobiology.
    • Continued research is advancing the treatment of CNV.